講演情報
[S-36-1]我が国のALS患者レジストリ（JaCALS）を基盤としたALS治療開発戦略
熱田 直樹1, 中村 亮一1, 藤内 玄規2, 祖父江 元3 (1.愛知医科大学医学部 内科学講座（神経内科）, 2.愛知医科大学ALS治療研究開発部門, 3.愛知医科大学)
Naoki Atsuta graduated from Nagoya University School of Medicine in 1996. After completing his clinical training, he became a neurologist and earned his degree from Nagoya University Graduate School of Medicine. He served as the ward chief of Neurology at Nagoya University Hospital from 2009 to 2020. Since November 2020, he has been working as an Associate Professor at Aichi Medical University.
Since 2005, he has been a central contributor to the establishment, operation, and analysis of JaCALS, a registry of ALS patients in Japan. He has also participated as a site principal investigator (PI) in many ALS clinical trials, including those for edaravone and methylcobalamin. Additionally, he is a member of the ALS Clinical Guidelines Committee of the Japanese Society of Neurology and is also a member of the committee working on the clinical evaluation guidelines for ALS clinical trials.
Since 2005, he has been a central contributor to the establishment, operation, and analysis of JaCALS, a registry of ALS patients in Japan. He has also participated as a site principal investigator (PI) in many ALS clinical trials, including those for edaravone and methylcobalamin. Additionally, he is a member of the ALS Clinical Guidelines Committee of the Japanese Society of Neurology and is also a member of the committee working on the clinical evaluation guidelines for ALS clinical trials.